Viewing Study NCT07105592


Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2025-12-26 @ 2:12 AM
Study NCT ID: NCT07105592
Status: RECRUITING
Last Update Posted: 2025-08-06
First Post: 2025-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module